This topic contains a solution. Click here to go to the answer

Author Question: A patient is being discharged to his home on enoxaparin (Lovenox) injections for treatment of deep ... (Read 69 times)

mia

  • Hero Member
  • *****
  • Posts: 564
A patient is being discharged to his home on enoxaparin (Lovenox) injections for treatment of deep vein thrombosis (DVT). Which of the following statements made by the patient indicates a need for further discharge teaching by the nurse?
 
  a. I will inject the enoxaparin into the fatty tissue of my abdomen.
  b. I hate needles, but I know enoxaparin doesn't come in pill form.
  c. I will need to go to my doctor's office each day to have my blood drawn to see whether enoxaparin is working.
  d. I will call my physician immediately if I experience any uncontrollable bleeding while on enoxaparin.

Question 2

A patient applies a transdermal nitroglycerin patch at 0900. What additional instruction should be provided by the nurse regarding the patch?
 
  a. Leave the patch in place until the following morning, when a new patch will be applied.
  b. Apply an additional patch if breakthrough anginal pain occurs.
  c. Remove the patch at 9 PM.
  d. Note the location of the patch, so that it can be reapplied in the same location to enhance absorption.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

14vl19

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

ANS: C
The half-life of a low-molecular-weight (LMW) heparin, such as enoxaparin, is up to six times longer than that of unfractionated heparin. Less binding to macrophages and slower clearance by the liver are also factors. Because of enoxaparin's increased bioavailability, the plasma levels of the drug are highly predictable. As a result, it can be given on a fixed schedule with no need for routine monitoring of coagulation.
Enoxaparin is administered subcutaneously (into fatty tissue), and the abdomen is a correct injection site.
LMW heparins, such as enoxaparin, are available only for subcutaneous injection.
Bleeding is the major adverse effect and should be reported if it does not cease.

Answer to Question 2

ANS: C
A daily patch free interval of 10 to 12 hours is recommended. This can be accomplished by applying a new patch each morning, leaving it in place for 12 to14 hours, and then removing it in the evening.
A daily patch free interval of 10 to 12 hours is recommended. This can be accomplished by applying a new patch each morning, leaving it in place for 12 to14 hours, and then removing it in the evening.
An additional patch is never indicated, because hypotension may occur.
Patches should be rotated to different areas to prevent irritation and skin breakdown.




mia

  • Member
  • Posts: 564
Reply 2 on: Jul 23, 2018
:D TYSM


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
Excellent

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library